Literature DB >> 18684816

Bap31 is a novel target of the human papillomavirus E5 protein.

Jennifer A Regan1, Laimonis A Laimins.   

Abstract

The E5 proteins of human papillomaviruses (HPVs) are small hydrophobic proteins that are expressed in the early and late stages of the viral life cycle; however, their role in HPV pathogenesis is not clearly understood. In this study, a split-ubiquitin yeast (Saccharomyces cerevisiae) two-hybrid system was used to identify B-cell-associated protein 31 (Bap31) as a binding partner of HPV E5 proteins. The association of these proteins was confirmed by coimmunoprecipitation of complexes of Bap31 with either HPV type 16 (HPV16) or HPV31 E5. In addition, Bap31 and E5 were found to colocalize in perinuclear patterns consistent with localization to the endoplasmic reticulum. Mutational analysis of E5 identified amino acids in the extreme C terminus as important for stabilizing the interaction with Bap31. Deletion of these C-terminal amino acids of E5 in the context of complete HPV31 genomes resulted in impaired proliferative capacity of HPV-positive keratinocytes following differentiation. When small interfering RNAs were used to reduce the levels of Bap31, the proliferative ability of HPV-positive keratinocytes upon differentiation was also reduced, implicating Bap31 as a regulator of this process. These studies identify a novel binding partner of the high-risk HPV E5 proteins and provide insight into how the E5 proteins may modulate the life cycle in differentiating cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18684816      PMCID: PMC2566283          DOI: 10.1128/JVI.01240-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Control of cystic fibrosis transmembrane conductance regulator expression by BAP31.

Authors:  G Lambert; B Becker; R Schreiber; A Boucherot; M Reth; K Kunzelmann
Journal:  J Biol Chem       Date:  2001-03-26       Impact factor: 5.157

2.  The procaspase-8 isoform, procaspase-8L, recruited to the BAP31 complex at the endoplasmic reticulum.

Authors:  David G Breckenridge; Mai Nguyen; Stephan Kuppig; Michael Reth; Gordon C Shore
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

3.  The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes.

Authors:  S W Straight; B Herman; D J McCance
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

4.  Split ubiquitin as a sensor of protein interactions in vivo.

Authors:  N Johnsson; A Varshavsky
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

5.  Caspase-resistant BAP31 inhibits fas-mediated apoptotic membrane fragmentation and release of cytochrome c from mitochondria.

Authors:  M Nguyen; D G Breckenridge; A Ducret; G C Shore
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

6.  Binding of human papillomavirus 16 E5 to the 16 kDa subunit c (proteolipid) of the vacuolar H+-ATPase can be dissociated from the E5-mediated epidermal growth factor receptor overactivation.

Authors:  M I Rodríguez; M E Finbow; A Alonso
Journal:  Oncogene       Date:  2000-08-03       Impact factor: 9.867

7.  The HPV16 E5 protein: expression, detection, and stable complex formation with transmembrane proteins in COS cells.

Authors:  E S Hwang; T Nottoli; D Dimaio
Journal:  Virology       Date:  1995-08-01       Impact factor: 3.616

8.  Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes.

Authors:  S Cheng; D C Schmidt-Grimminger; T Murant; T R Broker; L T Chow
Journal:  Genes Dev       Date:  1995-10-01       Impact factor: 11.361

9.  The human papillomavirus (HPV)-6 and HPV-16 E5 proteins co-operate with HPV-16 E7 in the transformation of primary rodent cells.

Authors:  G F Valle; L Banks
Journal:  J Gen Virol       Date:  1995-05       Impact factor: 3.891

10.  The specificity of association of the IgD molecule with the accessory proteins BAP31/BAP29 lies in the IgD transmembrane sequence.

Authors:  T Adachi; W W Schamel; K M Kim; T Watanabe; B Becker; P J Nielsen; M Reth
Journal:  EMBO J       Date:  1996-04-01       Impact factor: 11.598

View more
  40 in total

Review 1.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

2.  The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification.

Authors:  Frank A Suprynowicz; Ewa Krawczyk; Jess D Hebert; Sawali R Sudarshan; Vera Simic; Christopher M Kamonjoh; Richard Schlegel
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

3.  E5 can be expressed in anal cancer and leads to epidermal growth factor receptor-induced invasion in a human papillomavirus 16-transformed anal epithelial cell line.

Authors:  Erin Isaacson Wechsler; Sharof Tugizov; Rossana Herrera; Maria Da Costa; Joel M Palefsky
Journal:  J Gen Virol       Date:  2018-04-06       Impact factor: 3.891

4.  The canine papillomavirus e5 protein signals from the endoplasmic reticulum.

Authors:  Rachel Condjella; Xuefeng Liu; Frank Suprynowicz; Hang Yuan; Sawali Sudarshan; Yuhai Dai; Richard Schlegel
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

5.  Membrane orientation of the human papillomavirus type 16 E5 oncoprotein.

Authors:  Ewa Krawczyk; Frank A Suprynowicz; Sawali R Sudarshan; Richard Schlegel
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

6.  Suppression of STAT-1 expression by human papillomaviruses is necessary for differentiation-dependent genome amplification and plasmid maintenance.

Authors:  Shiyuan Hong; Kavi P Mehta; Laimonis A Laimins
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

7.  HPV 16 E5 oncoprotein is expressed in early stage carcinogenesis and can be a target of immunotherapy.

Authors:  Francesca Paolini; Gianfranca Curzio; Marcelo Nazario Cordeiro; Silvia Massa; Luciano Mariani; Fulvia Pimpinelli; Antonio Carlos de Freitas; Rosella Franconi; Aldo Venuti
Journal:  Hum Vaccin Immunother       Date:  2016-12-08       Impact factor: 3.452

Review 8.  Human papillomavirus oncoproteins: pathways to transformation.

Authors:  Cary A Moody; Laimonis A Laimins
Journal:  Nat Rev Cancer       Date:  2010-07-01       Impact factor: 60.716

9.  Quantitative measurement of human papillomavirus type 16 e5 oncoprotein levels in epithelial cell lines by mass spectrometry.

Authors:  Ziad Sahab; Sawali R Sudarshan; Xuefeng Liu; YiYu Zhang; Alexander Kirilyuk; Christopher M Kamonjoh; Vera Simic; Yuhai Dai; Stephen W Byers; John Doorbar; Frank A Suprynowicz; Richard Schlegel
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

10.  Membrane-Associated RING-CH proteins associate with Bap31 and target CD81 and CD44 to lysosomes.

Authors:  Eric Bartee; Craig A Eyster; Kasinath Viswanathan; Mandana Mansouri; Julie G Donaldson; Klaus Früh
Journal:  PLoS One       Date:  2010-12-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.